CLINICAL_TRIALS
research
· 2026-03-23
Clinical Trial Update: An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis [Phase 1]
Summary
This is a Phase 1 ascending-dose study of PIT565 in participants with rheumatoid arthritis, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 1 | Status: RECRUITING